Therefore, to more precisely study the role of HDACs in cancerous transformation, we also treated genetic variants of HT-29 colon cancer cell lines that model varying aggressiveness with a pharmacological HDAC inhibitor (HDACI). The gene discussed is HDAC9; the disease is colonic neoplasm.